id	sid	tid	token	lemma	pos
gs-4251	1	1	georgian	georgian	PROPN
gs-4251	1	2	scientists/	scientists/	NUM
gs-4251	1	3	.	.	PUNCT
gs-4251	2	1	7	7	NUM
gs-4251	2	2	n	n	DET
gs-4251	2	3	4(1	4(1	NOUN
gs-4251	2	4	)	)	PUNCT
gs-4251	2	5	,	,	PUNCT
gs-4251	2	6	2025	2025	NUM
gs-4251	2	7	3	3	NUM
gs-4251	2	8	georgian	georgian	PROPN
gs-4251	2	9	scientists	scientist	NOUN
gs-4251	2	10	vol	vol	NOUN
gs-4251	2	11	.	.	PUNCT
gs-4251	3	1	7	7	NUM
gs-4251	3	2	issue	issue	NOUN
gs-4251	3	3	4(1	4(1	NOUN
gs-4251	3	4	)	)	PUNCT
gs-4251	3	5	,	,	PUNCT
gs-4251	3	6	2025	2025	NUM
gs-4251	3	7	https://doi.org/10.52340/gs.2025.07.04(1).03	https://doi.org/10.52340/gs.2025.07.04(1).03	NUM
gs-4251	3	8	novelties	novelty	NOUN
gs-4251	3	9	in	in	ADP
gs-4251	3	10	the	the	DET
gs-4251	3	11	pharmacotherapy	pharmacotherapy	NOUN
gs-4251	3	12	of	of	ADP
gs-4251	3	13	acute	acute	ADJ
gs-4251	3	14	respiratory	respiratory	ADJ
gs-4251	3	15	distress	distress	NOUN
gs-4251	3	16	syndrome	syndrome	PROPN
gs-4251	3	17	luiza	luiza	PROPN
gs-4251	3	18	gabunia1	gabunia1	PROPN
gs-4251	3	19	,	,	PUNCT
gs-4251	3	20	shorena	shorena	PROPN
gs-4251	3	21	khetsuriani2	khetsuriani2	PROPN
gs-4251	3	22	,	,	PUNCT
gs-4251	3	23	gvantsa	gvantsa	VERB
gs-4251	3	24	janigashvili3	janigashvili3	PROPN
gs-4251	3	25	,	,	PUNCT
gs-4251	3	26	nodari	nodari	NOUN
gs-4251	3	27	sulashvili4	sulashvili4	VERB
gs-4251	3	28	1	1	NUM
gs-4251	3	29	.	.	PUNCT
gs-4251	3	30	department	department	NOUN
gs-4251	3	31	of	of	ADP
gs-4251	3	32	clinical	clinical	ADJ
gs-4251	3	33	pharmacology	pharmacology	NOUN
gs-4251	3	34	,	,	PUNCT
gs-4251	3	35	scientific	scientific	ADJ
gs-4251	3	36	skills	skill	NOUN
gs-4251	3	37	center	center	NOUN
gs-4251	3	38	,	,	PUNCT
gs-4251	3	39	tbilisi	tbilisi	PROPN
gs-4251	3	40	state	state	PROPN
gs-4251	3	41	medical	medical	PROPN
gs-4251	3	42	university	university	PROPN
gs-4251	3	43	,	,	PUNCT
gs-4251	3	44	tbilisi	tbilisi	PROPN
gs-4251	3	45	,	,	PUNCT
gs-4251	3	46	georgia	georgia	PROPN
gs-4251	3	47	2	2	NUM
gs-4251	3	48	.	.	PUNCT
gs-4251	3	49	department	department	NOUN
gs-4251	3	50	of	of	ADP
gs-4251	3	51	microbiology	microbiology	NOUN
gs-4251	3	52	,	,	PUNCT
gs-4251	3	53	tbilisi	tbilisi	PROPN
gs-4251	3	54	state	state	PROPN
gs-4251	3	55	medical	medical	PROPN
gs-4251	3	56	university	university	PROPN
gs-4251	3	57	,	,	PUNCT
gs-4251	3	58	tbilisi	tbilisi	PROPN
gs-4251	3	59	,	,	PUNCT
gs-4251	3	60	georgia	georgia	PROPN
gs-4251	3	61	3	3	NUM
gs-4251	3	62	.	.	PUNCT
gs-4251	4	1	department	department	NOUN
gs-4251	4	2	of	of	ADP
gs-4251	4	3	clinical	clinical	ADJ
gs-4251	4	4	pharmacology	pharmacology	NOUN
gs-4251	4	5	,	,	PUNCT
gs-4251	4	6	tbilisi	tbilisi	PROPN
gs-4251	4	7	state	state	PROPN
gs-4251	4	8	medical	medical	PROPN
gs-4251	4	9	university	university	PROPN
gs-4251	4	10	,	,	PUNCT
gs-4251	4	11	tbilisi	tbilisi	PROPN
gs-4251	4	12	,	,	PUNCT
gs-4251	4	13	georgia	georgia	PROPN
gs-4251	4	14	4	4	NUM
gs-4251	4	15	.	.	PUNCT
gs-4251	5	1	department	department	NOUN
gs-4251	5	2	of	of	ADP
gs-4251	5	3	clinical	clinical	ADJ
gs-4251	5	4	pharmacology	pharmacology	NOUN
gs-4251	5	5	,	,	PUNCT
gs-4251	5	6	tbilisi	tbilisi	PROPN
gs-4251	5	7	state	state	PROPN
gs-4251	5	8	medical	medical	PROPN
gs-4251	5	9	university	university	PROPN
gs-4251	5	10	,	,	PUNCT
gs-4251	5	11	tbilisi	tbilisi	PROPN
gs-4251	5	12	,	,	PUNCT
gs-4251	5	13	georgia	georgia	PROPN
gs-4251	5	14	acute	acute	PROPN
gs-4251	5	15	respiratory	respiratory	ADJ
gs-4251	5	16	distress	distress	NOUN
gs-4251	5	17	syndrome	syndrome	NOUN
gs-4251	5	18	(	(	PUNCT
gs-4251	5	19	ards	ard	NOUN
gs-4251	5	20	)	)	PUNCT
gs-4251	5	21	is	be	AUX
gs-4251	5	22	characterized	characterize	VERB
gs-4251	5	23	by	by	ADP
gs-4251	5	24	a	a	DET
gs-4251	5	25	rapid	rapid	ADJ
gs-4251	5	26	onset	onset	NOUN
gs-4251	5	27	of	of	ADP
gs-4251	5	28	hypoxemia	hypoxemia	NOUN
gs-4251	5	29	and	and	CCONJ
gs-4251	5	30	bilateral	bilateral	ADJ
gs-4251	5	31	pulmonary	pulmonary	NOUN
gs-4251	5	32	infiltrates	infiltrate	NOUN
gs-4251	5	33	not	not	PART
gs-4251	5	34	fully	fully	ADV
gs-4251	5	35	explained	explain	VERB
gs-4251	5	36	by	by	ADP
gs-4251	5	37	cardiac	cardiac	ADJ
gs-4251	5	38	failure	failure	NOUN
gs-4251	5	39	or	or	CCONJ
gs-4251	5	40	fluid	fluid	ADJ
gs-4251	5	41	overload	overload	NOUN
gs-4251	5	42	.	.	PUNCT
gs-4251	6	1	for	for	ADP
gs-4251	6	2	decades	decade	NOUN
gs-4251	6	3	,	,	PUNCT
gs-4251	6	4	ards	ard	NOUN
gs-4251	6	5	management	management	NOUN
gs-4251	6	6	has	have	AUX
gs-4251	6	7	relied	rely	VERB
gs-4251	6	8	on	on	ADP
gs-4251	6	9	supportive	supportive	ADJ
gs-4251	6	10	,	,	PUNCT
gs-4251	6	11	non	non	ADJ
gs-4251	6	12	-	-	ADJ
gs-4251	6	13	pharmacological	pharmacological	ADJ
gs-4251	6	14	interventions	intervention	NOUN
gs-4251	6	15	to	to	PART
gs-4251	6	16	mitigate	mitigate	VERB
gs-4251	6	17	lung	lung	NOUN
gs-4251	6	18	injury	injury	NOUN
gs-4251	6	19	and	and	CCONJ
gs-4251	6	20	optimize	optimize	VERB
gs-4251	6	21	gas	gas	NOUN
gs-4251	6	22	exchange	exchange	NOUN
gs-4251	6	23	.	.	PUNCT
gs-4251	7	1	recent	recent	ADJ
gs-4251	7	2	clinical	clinical	ADJ
gs-4251	7	3	trials	trial	NOUN
gs-4251	7	4	have	have	AUX
gs-4251	7	5	re	re	VERB
gs-4251	7	6	-	-	VERB
gs-4251	7	7	evaluated	evaluated	ADJ
gs-4251	7	8	corticosteroid	corticosteroid	ADJ
gs-4251	7	9	use	use	NOUN
gs-4251	7	10	in	in	ADP
gs-4251	7	11	ards	ard	NOUN
gs-4251	7	12	,	,	PUNCT
gs-4251	7	13	showing	show	VERB
gs-4251	7	14	significant	significant	ADJ
gs-4251	7	15	mortality	mortality	NOUN
gs-4251	7	16	benefits	benefit	NOUN
gs-4251	7	17	.	.	PUNCT
gs-4251	8	1	in	in	ADP
gs-4251	8	2	the	the	DET
gs-4251	8	3	dexa	dexa	ADJ
gs-4251	8	4	-	-	PUNCT
gs-4251	8	5	ards	ard	NOUN
gs-4251	8	6	trial	trial	NOUN
gs-4251	8	7	,	,	PUNCT
gs-4251	8	8	ards	ard	NOUN
gs-4251	8	9	patients	patient	NOUN
gs-4251	8	10	received	receive	VERB
gs-4251	8	11	dexamethasone	dexamethasone	NOUN
gs-4251	8	12	,	,	PUNCT
gs-4251	8	13	which	which	PRON
gs-4251	8	14	reduced	reduce	VERB
gs-4251	8	15	60	60	NUM
gs-4251	8	16	-	-	PUNCT
gs-4251	8	17	day	day	NOUN
gs-4251	8	18	mortality	mortality	NOUN
gs-4251	8	19	and	and	CCONJ
gs-4251	8	20	increased	increase	VERB
gs-4251	8	21	ventilator	ventilator	NOUN
gs-4251	8	22	-	-	PUNCT
gs-4251	8	23	free	free	ADJ
gs-4251	8	24	days	day	NOUN
gs-4251	8	25	.	.	PUNCT
gs-4251	9	1	in	in	ADP
gs-4251	9	2	the	the	DET
gs-4251	9	3	recovery	recovery	NOUN
gs-4251	9	4	trial	trial	NOUN
gs-4251	9	5	large	large	ADJ
gs-4251	9	6	cohort	cohort	NOUN
gs-4251	9	7	,	,	PUNCT
gs-4251	9	8	covid-19	covid-19	PROPN
gs-4251	9	9	patients	patient	NOUN
gs-4251	9	10	with	with	ADP
gs-4251	9	11	ards	ard	NOUN
gs-4251	9	12	,	,	PUNCT
gs-4251	9	13	who	who	PRON
gs-4251	9	14	received	receive	VERB
gs-4251	9	15	dexamethasone	dexamethasone	NOUN
gs-4251	9	16	,	,	PUNCT
gs-4251	9	17	reduced	reduce	VERB
gs-4251	9	18	28	28	NUM
gs-4251	9	19	-	-	PUNCT
gs-4251	9	20	day	day	NOUN
gs-4251	9	21	mortality	mortality	NOUN
gs-4251	9	22	.	.	PUNCT
gs-4251	10	1	jak	jak	PROPN
gs-4251	10	2	inhibitors	inhibitor	NOUN
gs-4251	10	3	(	(	PUNCT
gs-4251	10	4	baricitinib	baricitinib	NOUN
gs-4251	10	5	)	)	PUNCT
gs-4251	10	6	target	target	VERB
gs-4251	10	7	the	the	DET
gs-4251	10	8	janus	janus	PROPN
gs-4251	10	9	kinase	kinase	PROPN
gs-4251	10	10	(	(	PUNCT
gs-4251	10	11	jak	jak	PROPN
gs-4251	10	12	)	)	PUNCT
gs-4251	10	13	pathway	pathway	NOUN
gs-4251	10	14	,	,	PUNCT
gs-4251	10	15	crucial	crucial	ADJ
gs-4251	10	16	for	for	ADP
gs-4251	10	17	cytokine	cytokine	NOUN
gs-4251	10	18	signaling	signal	VERB
gs-4251	10	19	and	and	CCONJ
gs-4251	10	20	immune	immune	ADJ
gs-4251	10	21	cell	cell	NOUN
gs-4251	10	22	activation	activation	NOUN
gs-4251	10	23	.	.	PUNCT
gs-4251	11	1	oral	oral	ADJ
gs-4251	11	2	jak1/2	jak1/2	PROPN
gs-4251	11	3	inhibitor	inhibitor	NOUN
gs-4251	11	4	shows	show	VERB
gs-4251	11	5	promise	promise	NOUN
gs-4251	11	6	in	in	ADP
gs-4251	11	7	covid-19	covid-19	PROPN
gs-4251	11	8	patients	patient	NOUN
gs-4251	11	9	with	with	ADP
gs-4251	11	10	ards	ard	NOUN
gs-4251	11	11	,	,	PUNCT
gs-4251	11	12	reduces	reduce	VERB
gs-4251	11	13	inflammation	inflammation	NOUN
gs-4251	11	14	,	,	PUNCT
gs-4251	11	15	and	and	CCONJ
gs-4251	11	16	improves	improve	VERB
gs-4251	11	17	clinical	clinical	ADJ
gs-4251	11	18	outcomes	outcome	NOUN
gs-4251	11	19	.	.	PUNCT
gs-4251	12	1	il-6	il-6	NOUN
gs-4251	12	2	receptor	receptor	NOUN
gs-4251	12	3	antagonists	antagonist	NOUN
gs-4251	12	4	(	(	PUNCT
gs-4251	12	5	tocilizumab	tocilizumab	NOUN
gs-4251	12	6	and	and	CCONJ
gs-4251	12	7	sarilumab	sarilumab	NOUN
gs-4251	12	8	)	)	PUNCT
gs-4251	12	9	block	block	VERB
gs-4251	12	10	the	the	DET
gs-4251	12	11	il-6	il-6	NOUN
gs-4251	12	12	receptor	receptor	NOUN
gs-4251	12	13	,	,	PUNCT
gs-4251	12	14	inhibiting	inhibit	VERB
gs-4251	12	15	its	its	PRON
gs-4251	12	16	inflammatory	inflammatory	ADJ
gs-4251	12	17	effects	effect	NOUN
gs-4251	12	18	.	.	PUNCT
gs-4251	13	1	target	target	VERB
gs-4251	13	2	il-6	il-6	NOUN
gs-4251	13	3	,	,	PUNCT
gs-4251	13	4	a	a	DET
gs-4251	13	5	key	key	ADJ
gs-4251	13	6	proinflammatory	proinflammatory	ADJ
gs-4251	13	7	cytokine	cytokine	NOUN
gs-4251	13	8	,	,	PUNCT
gs-4251	13	9	is	be	AUX
gs-4251	13	10	particularly	particularly	ADV
gs-4251	13	11	effective	effective	ADJ
gs-4251	13	12	in	in	ADP
gs-4251	13	13	patients	patient	NOUN
gs-4251	13	14	with	with	ADP
gs-4251	13	15	high	high	ADJ
gs-4251	13	16	inflammatory	inflammatory	ADJ
gs-4251	13	17	markers	marker	NOUN
gs-4251	13	18	.	.	PUNCT
gs-4251	14	1	initial	initial	ADJ
gs-4251	14	2	studies	study	NOUN
gs-4251	14	3	in	in	ADP
gs-4251	14	4	covid-19	covid-19	PROPN
gs-4251	14	5	ards	ard	NOUN
gs-4251	14	6	showed	show	VERB
gs-4251	14	7	mixed	mixed	ADJ
gs-4251	14	8	results	result	NOUN
gs-4251	14	9	.	.	PUNCT
gs-4251	15	1	research	research	NOUN
gs-4251	15	2	continues	continue	VERB
gs-4251	15	3	into	into	ADP
gs-4251	15	4	other	other	ADJ
gs-4251	15	5	agents	agent	NOUN
gs-4251	15	6	targeting	target	VERB
gs-4251	15	7	various	various	ADJ
gs-4251	15	8	inflammatory	inflammatory	ADJ
gs-4251	15	9	pathways	pathway	NOUN
gs-4251	15	10	:	:	PUNCT
gs-4251	15	11	tnf	tnf	VERB
gs-4251	15	12	-	-	PUNCT
gs-4251	15	13	alpha	alpha	NOUN
gs-4251	15	14	inhibitors	inhibitor	NOUN
gs-4251	15	15	and	and	CCONJ
gs-4251	15	16	complement	complement	VERB
gs-4251	15	17	inhibitors	inhibitor	NOUN
gs-4251	15	18	block	block	VERB
gs-4251	15	19	complement	complement	NOUN
gs-4251	15	20	system	system	NOUN
gs-4251	15	21	activation	activation	NOUN
gs-4251	15	22	.	.	PUNCT
gs-4251	16	1	these	these	DET
gs-4251	16	2	agents	agent	NOUN
gs-4251	16	3	target	target	VERB
gs-4251	16	4	different	different	ADJ
gs-4251	16	5	points	point	NOUN
gs-4251	16	6	in	in	ADP
gs-4251	16	7	the	the	DET
gs-4251	16	8	inflammatory	inflammatory	ADJ
gs-4251	16	9	cascade	cascade	NOUN
gs-4251	16	10	still	still	ADV
gs-4251	16	11	investigational	investigational	ADJ
gs-4251	16	12	for	for	ADP
gs-4251	16	13	ards	ard	NOUN
gs-4251	16	14	.	.	PUNCT
gs-4251	17	1	they	they	PRON
gs-4251	17	2	block	block	VERB
gs-4251	17	3	specific	specific	ADJ
gs-4251	17	4	inflammatory	inflammatory	ADJ
gs-4251	17	5	pathways	pathway	NOUN
gs-4251	17	6	,	,	PUNCT
gs-4251	17	7	reduce	reduce	VERB
gs-4251	17	8	cytokine	cytokine	NOUN
gs-4251	17	9	release	release	NOUN
gs-4251	17	10	,	,	PUNCT
gs-4251	17	11	protect	protect	VERB
gs-4251	17	12	alveolar	alveolar	ADJ
gs-4251	17	13	-	-	PUNCT
gs-4251	17	14	capillary	capillary	ADJ
gs-4251	17	15	barrier	barrier	NOUN
gs-4251	17	16	,	,	PUNCT
gs-4251	17	17	and	and	CCONJ
gs-4251	17	18	modulate	modulate	VERB
gs-4251	17	19	immune	immune	ADJ
gs-4251	17	20	cell	cell	NOUN
gs-4251	17	21	function	function	NOUN
gs-4251	17	22	.	.	PUNCT
gs-4251	18	1	statins	statin	NOUN
gs-4251	18	2	reduce	reduce	VERB
gs-4251	18	3	inflammation	inflammation	NOUN
gs-4251	18	4	and	and	CCONJ
gs-4251	18	5	improve	improve	VERB
gs-4251	18	6	lung	lung	NOUN
gs-4251	18	7	function	function	NOUN
gs-4251	18	8	in	in	ADP
gs-4251	18	9	ards	ard	NOUN
gs-4251	18	10	patients	patient	NOUN
gs-4251	18	11	.	.	PUNCT
gs-4251	19	1	anticoagulants	anticoagulant	NOUN
gs-4251	19	2	prevent	prevent	VERB
gs-4251	19	3	microvascular	microvascular	NOUN
gs-4251	19	4	thrombosis	thrombosis	NOUN
gs-4251	19	5	and	and	CCONJ
gs-4251	19	6	improve	improve	VERB
gs-4251	19	7	pulmonary	pulmonary	ADJ
gs-4251	19	8	perfusion	perfusion	NOUN
gs-4251	19	9	.	.	PUNCT
gs-4251	20	1	novel	novel	ADJ
gs-4251	20	2	endothelial	endothelial	ADJ
gs-4251	20	3	barrier	barrier	NOUN
gs-4251	20	4	stabilizers	stabilizer	NOUN
gs-4251	20	5	reduce	reduce	VERB
gs-4251	20	6	pulmonary	pulmonary	ADJ
gs-4251	20	7	edema	edema	NOUN
gs-4251	20	8	and	and	CCONJ
gs-4251	20	9	improve	improve	VERB
gs-4251	20	10	lung	lung	NOUN
gs-4251	20	11	function	function	NOUN
gs-4251	20	12	.	.	PUNCT
gs-4251	21	1	cell	cell	NOUN
gs-4251	21	2	-	-	PUNCT
gs-4251	21	3	based	base	VERB
gs-4251	21	4	therapies	therapy	NOUN
gs-4251	21	5	mesenchymal	mesenchymal	NOUN
gs-4251	21	6	stem	stem	NOUN
gs-4251	21	7	/	/	SYM
gs-4251	21	8	stromal	stromal	ADJ
gs-4251	21	9	cells	cell	NOUN
gs-4251	21	10	(	(	PUNCT
gs-4251	21	11	mscs	msc	NOUN
gs-4251	21	12	)	)	PUNCT
gs-4251	21	13	demonstrate	demonstrate	VERB
gs-4251	21	14	immunomodulatory	immunomodulatory	ADJ
gs-4251	21	15	and	and	CCONJ
gs-4251	21	16	regenerative	regenerative	ADJ
gs-4251	21	17	properties	property	NOUN
gs-4251	21	18	,	,	PUNCT
gs-4251	21	19	show	show	VERB
gs-4251	21	20	safety	safety	NOUN
gs-4251	21	21	,	,	PUNCT
gs-4251	21	22	and	and	CCONJ
gs-4251	21	23	potential	potential	ADJ
gs-4251	21	24	efficacy	efficacy	NOUN
gs-4251	21	25	.	.	PUNCT
gs-4251	22	1	personalized	personalized	ADJ
gs-4251	22	2	medicine	medicine	NOUN
gs-4251	22	3	is	be	AUX
gs-4251	22	4	moving	move	VERB
gs-4251	22	5	toward	toward	ADP
gs-4251	22	6	phenotype	phenotype	NOUN
gs-4251	22	7	-	-	PUNCT
gs-4251	22	8	guided	guide	VERB
gs-4251	22	9	treatment	treatment	NOUN
gs-4251	22	10	to	to	PART
gs-4251	22	11	identify	identify	VERB
gs-4251	22	12	patient	patient	ADJ
gs-4251	22	13	subgroups	subgroup	NOUN
gs-4251	22	14	most	most	ADV
gs-4251	22	15	likely	likely	ADJ
gs-4251	22	16	to	to	PART
gs-4251	22	17	benefit	benefit	VERB
gs-4251	22	18	from	from	ADP
gs-4251	22	19	specific	specific	ADJ
gs-4251	22	20	therapies	therapy	NOUN
gs-4251	22	21	.	.	PUNCT
gs-4251	23	1	it	it	PRON
gs-4251	23	2	offers	offer	VERB
gs-4251	23	3	us	we	PRON
gs-4251	23	4	moving	move	VERB
gs-4251	23	5	beyond	beyond	ADP
gs-4251	23	6	a	a	DET
gs-4251	23	7	"	"	PUNCT
gs-4251	23	8	one	one	NUM
gs-4251	23	9	-	-	PUNCT
gs-4251	23	10	size	size	NOUN
gs-4251	23	11	-	-	PUNCT
gs-4251	23	12	fits	fit	VERB
gs-4251	23	13	-	-	PUNCT
gs-4251	23	14	all	all	PRON
gs-4251	23	15	"	"	PUNCT
gs-4251	23	16	approach	approach	NOUN
gs-4251	23	17	by	by	ADP
gs-4251	23	18	identifying	identify	VERB
gs-4251	23	19	distinct	distinct	ADJ
gs-4251	23	20	ards	ard	NOUN
gs-4251	23	21	phenotypes	phenotype	NOUN
gs-4251	23	22	and	and	CCONJ
gs-4251	23	23	endotypes	endotype	NOUN
gs-4251	23	24	to	to	PART
gs-4251	23	25	tailor	tailor	VERB
gs-4251	23	26	treatments	treatment	NOUN
gs-4251	23	27	more	more	ADV
gs-4251	23	28	effectively	effectively	ADV
gs-4251	23	29	.	.	PUNCT
gs-4251	24	1	ongoing	ongoing	ADJ
gs-4251	24	2	clinical	clinical	ADJ
gs-4251	24	3	trials	trial	NOUN
gs-4251	24	4	involve	involve	VERB
gs-4251	24	5	essential	essential	ADJ
gs-4251	24	6	validation	validation	NOUN
gs-4251	24	7	of	of	ADP
gs-4251	24	8	emerging	emerge	VERB
gs-4251	24	9	therapies	therapy	NOUN
gs-4251	24	10	,	,	PUNCT
gs-4251	24	11	refinement	refinement	NOUN
gs-4251	24	12	of	of	ADP
gs-4251	24	13	treatment	treatment	NOUN
gs-4251	24	14	protocols	protocol	NOUN
gs-4251	24	15	,	,	PUNCT
gs-4251	24	16	and	and	CCONJ
gs-4251	24	17	integration	integration	NOUN
gs-4251	24	18	of	of	ADP
gs-4251	24	19	novel	novel	ADJ
gs-4251	24	20	pharmacological	pharmacological	ADJ
gs-4251	24	21	agents	agent	NOUN
gs-4251	24	22	into	into	ADP
gs-4251	24	23	standard	standard	ADJ
gs-4251	24	24	care	care	NOUN
gs-4251	24	25	.	.	PUNCT
gs-4251	25	1	understanding	understand	VERB
gs-4251	25	2	the	the	DET
gs-4251	25	3	complex	complex	ADJ
gs-4251	25	4	interplay	interplay	NOUN
gs-4251	25	5	of	of	ADP
gs-4251	25	6	inflammation	inflammation	NOUN
gs-4251	25	7	,	,	PUNCT
gs-4251	25	8	coagulation	coagulation	NOUN
gs-4251	25	9	,	,	PUNCT
gs-4251	25	10	and	and	CCONJ
gs-4251	25	11	tissue	tissue	NOUN
gs-4251	25	12	repair	repair	NOUN
gs-4251	25	13	in	in	ADP
gs-4251	25	14	ards	ard	NOUN
gs-4251	25	15	is	be	AUX
gs-4251	25	16	important	important	ADJ
gs-4251	25	17	for	for	ADP
gs-4251	25	18	developing	develop	VERB
gs-4251	25	19	more	more	ADV
gs-4251	25	20	targeted	targeted	ADJ
gs-4251	25	21	and	and	CCONJ
gs-4251	25	22	effective	effective	ADJ
gs-4251	25	23	interventions	intervention	NOUN
gs-4251	25	24	.	.	PUNCT
gs-4251	26	1	keywords	keyword	NOUN
gs-4251	26	2	:	:	PUNCT
gs-4251	26	3	acute	acute	ADJ
gs-4251	26	4	respiratory	respiratory	ADJ
gs-4251	26	5	distress	distress	NOUN
gs-4251	26	6	syndrome	syndrome	NOUN
gs-4251	26	7	,	,	PUNCT
gs-4251	26	8	pharmacotherapy	pharmacotherapy	NOUN
gs-4251	26	9	,	,	PUNCT
gs-4251	26	10	glucocorticoids	glucocorticoid	NOUN
gs-4251	26	11	,	,	PUNCT
gs-4251	26	12	personalized	personalized	ADJ
gs-4251	26	13	medicine	medicine	NOUN
gs-4251	26	14	.	.	PUNCT